219 related articles for article (PubMed ID: 27629286)
1. Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.
Taleb N; Haidar A; Messier V; Gingras V; Legault L; Rabasa-Lhoret R
Diabetes Obes Metab; 2017 Jan; 19(1):13-23. PubMed ID: 27629286
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
3. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
[TBL] [Abstract][Full Text] [Related]
5. Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.
Peters TM; Haidar A
Diabet Med; 2018 Apr; 35(4):450-459. PubMed ID: 29337384
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
7. A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy.
Bakhtiani PA; Zhao LM; El Youssef J; Castle JR; Ward WK
Diabetes Obes Metab; 2013 Dec; 15(12):1065-70. PubMed ID: 23602044
[TBL] [Abstract][Full Text] [Related]
8. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
Tang F; Wang Y
J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
[TBL] [Abstract][Full Text] [Related]
9. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
10. Diabetes: Artificial pancreas--first head-to-head comparison of dual-hormone and single-hormone systems.
Holmes D
Nat Rev Endocrinol; 2015 Feb; 11(2):63. PubMed ID: 25511314
[No Abstract] [Full Text] [Related]
11. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
[TBL] [Abstract][Full Text] [Related]
12. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
[TBL] [Abstract][Full Text] [Related]
13. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
Hövelmann U; Olsen MB; Mouritzen U; Lamers D; Kronshage B; Heise T
Diabetes Obes Metab; 2019 Mar; 21(3):601-610. PubMed ID: 30350477
[TBL] [Abstract][Full Text] [Related]
14. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
Infante M; Baidal DA; Rickels MR; Fabbri A; Skyler JS; Alejandro R; Ricordi C
Artif Organs; 2021 Sep; 45(9):968-986. PubMed ID: 34263961
[TBL] [Abstract][Full Text] [Related]
15. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.
Blauw H; van Bon AC; Koops R; DeVries JH;
Diabetes Obes Metab; 2016 Jul; 18(7):671-7. PubMed ID: 26996542
[TBL] [Abstract][Full Text] [Related]
16. Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.
Taleb N; Coriati A; Khazzaka C; Bayonne J; Messier V; Rabasa-Lhoret R
Diabetes Technol Ther; 2017 Oct; 19(10):589-594. PubMed ID: 28846447
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.
Taleb N; Emami A; Suppere C; Messier V; Legault L; Ladouceur M; Chiasson JL; Haidar A; Rabasa-Lhoret R
Diabetologia; 2016 Dec; 59(12):2561-2571. PubMed ID: 27704167
[TBL] [Abstract][Full Text] [Related]
18. Role of Glucagon in Automated Insulin Delivery.
Wilson LM; Jacobs PG; Castle JR
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
[TBL] [Abstract][Full Text] [Related]
19. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
20. The bionic pancreas: novel perspectives on insulin replacement therapies.
Denecke C
Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
